1. Statistics Korea. 2009.
2. Randoux B, Marro B, Koskas F, Duyme M, Sahel M, Zouaoui A, et al. Carotid artery stenosis: prospective comparison of CT, three-dimensional gadolinium-enhanced MR, and conventional angiography. Radiology. 2001. 220:179–185.
3. Mühlenbruch G, Das M, Mommertz G, Schaaf M, Langer S, Mahnken AH, et al. Comparison of dual-source CT angiography and MR angiography in preoperative evaluation of intra- and extracranial vessels: a pilot study. Eur Radiol. 2010. 20:469–476.
4. Babiarz LS, Romero JM, Murphy EK, Brobeck B, Schaefer PW, Gonzlez RG, et al. Contrast-enhanced MR angiography is not more accurate than unenhanced 2D time-of-flight MR angiography for determining > or = 70% internal carotid artery stenosis. AJNR Am J Neuroradiol. 2009. 30:761–768.
5. Alvarez Linera J, Benito-Len J, Escribano J, Campollo J, Gesto R. Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol. 2003. 24:1012–1019.
6. Sadikin C, Teng MM, Chen T, Luo C, Chang F, Lirng J, et al. The current role of 1.5T non-contrast 3D time-of-flight magnetic resonance angiography to detect intracranial steno-occlusive disease. Journal of the Formosan Medical Association. 2007. 106:691–699.
7. Lell M, Fellner C, Baum U, Hothorn T, Steiner R, Lang W, et al. Evaluation of carotid artery stenosis with multisection CT and MR imaging: influence of imaging modality and postprocessing. AJNR Am J Neuroradiol. 2007. 28:104–110.
8. Villablanca JP, Nael K, Habibi R, Nael A, Laub G, Finn JP. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography. Invest Radiol. 2006. 41:799–805.
9. Jang NK, Seo JJ, Chung TW, Jeong GW, Kim JK, Kang HK, Cho KH. The Usefulness of Enhanced 3D-TOF MR Angiography in the Patients with Cerebral Infarction: Comparison with Conventional Angiography. J Korean Radiol Soc. 2000. 42:575–583.
10. Atkinson D, Brant Zawadzki M, Gillan G, Purdy D, Laub G. Improved MR angiography: magnetization transfer suppression with variable flip angle excitation and increased resolution. Radiology. 1994. 190:890–894.
11. Townsend TC, Saloner D, Pan XM, Rapp JH. Contrast material-enhanced MRA overestimates severity of carotid stenosis, compared with 3D time-of-flight MRA. J Vasc Surg. 2003. 38:36–40.
12. DeMarco JK, Huston J, Bernstein MA. Evaluation of classic 2D time-of-flight MR angiography in the depiction of severe carotid stenosis. AJR Am J Roentgenol. 2004. 183:787–793.
13. Rasanen HT, Manninen HI, Vanninen RL, Vainio P, Berg M, Saari T. Mild carotid artery atherosclerosis: assessment by 3-dimensional time-of-flight magnetic resonance angiography, with reference to intravascular ultrasound imaging and contrast angiography. Stroke. 1999. 30:827–833.
14. Evans AJ, Richardson DB, Tien R, MacFall JR, Hedlund LW, Heinz ER, et al. Poststenotic signal loss in MR angiography: effects of echo time, flow compensation, and fractional echo. AJNR Am J Neuroradiol. 1993. 14:721–729.
15. Sardanelli F, Zandrino F, Parodi RC, De Caro G. MR angiography of internal carotid arteries: breath-hold Gd-enhanced 3D fast imaging with steady-state precession versus unenhanced 2D and 3D time-of-flight techniques. J Comput Assist Tomogr. 1999. 23:208–215.
16. Kramer H, Runge VM, Morelli JN, Williams KD, Naul LG, Nikolaou K, et al. Magnetic resonance angiography of the carotid arteries: comparison of unenhanced and contrast enhanced techniques. Eur Radiol. 2011.
17. Morcos SK. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol. 2007. 80:73–76.
18. Grobner T. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006. 21:1104–1108.
19. Port M, Ide J, Medina C, Robic C, Sabatou M, Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals. 2008. 21:469–490.
20. Morcos SK. Extracellular gadolinium contrast agents: differences in stability. Eur J Radiol. 2008. 66:175–179.